USPTO serial 99750838
FREXWAYVO
Reviewed by CopyMark Law Group
Status 681
- Filing date
- Status date
- Registration date
- —
- Examiner
- ELLINGER FATHY, JESSICA M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with FREXWAYVO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Alexandra Kochian
Alexandra Kochian Fross Zelnick Lehrman & Zissu, P.C.151 West 42nd St.,17th FLNew York, NY 10036Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment and prevention of autoimmune, immune-mediated, inflammatory and immunological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the central nervous system; Pharmaceutical preparations for the treatment and prevention of rare autoimmune, immune-mediated, inflammatory, immunological, central nervous system and neurological diseases and disorders | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 4, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 13, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 13, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 13, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 8, 2026 | ALIE | ASSIGNED TO LIE | — |
| Oct 6, 2026 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jun 9, 2026 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jun 9, 2026 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jun 9, 2026 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jun 9, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 8, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 8, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 8, 2026 | NWAP | NEW APPLICATION ENTERED | — |